Israel has achieved incredible milestones in a number of industries, including: cyber security, agricultural technology, data analysis, and now, medical marijuana. Not only is cannabis legal in the country, but the government is also working to create legislation that would allow for the export of medical cannabis products.
Though the Israeli government is just in the first stages of creating such legislation, there is already a list of national companies vying to get involved in the niche industry of medical cannabis exports. The companies come from a variety of industries and hope to make use of Israel’s unique climate and resources and liberal attitude toward medical marijuana.
One start-up, Syqe Medical, is interested in exporting its handheld inhaler, which dispenses marijuana in precise doses. The company recently signed a deal with the world’s largest maker of generic drugs, Teva Pharmaceuticals, to distribute the inhaler on a national scale. The product has also been successfully used for pain relief for over a year by patients at Haifa’s Ramban hospital.
“We’ve developed the world’s first meter-dose system for cannabis,” said Syqe’s chief execute, Perry Davidson.
Syqe’s inhaler reduces some of the concern about uncertainty of doses, as the amount of cannabis dispensed is measured down to the milligram. Such uncertainty has been a major concern for many healthcare professionals in countries around the world, especially the United States.
Companies in Britain, like the recently popular GW Pharmaceuticals, are also making strides in the medical marijuana industry. GW has one cannabis-based treatment that is approved for use in 29 countries and another that was successful in its first significant clinical trial.
Israel, though, is a unique case, for many reasons. First, its rightwing government has backed the medical cannabis industry by promoting its potential for creating jobs and encouraging investment. As a result, Israelis are much less limited in conducting academic research on cannabis—the isolation of cannabnioids, an active compound in cannabis, was pioneered by an Israeli researcher. The Israeli government also allows medical marijuana producers to conduct clinical trials on their products, which is forbidden in the United States.
In addition to the governmental conditions necessary for the cannabis industry to take off, Israel also has advanced agricultural and technological companies leading the charge for advancing medical marijuana in the country.
“I think Israel enjoys both the agricultural knowledge that is needed in order to grow marijuana, and the biotech knowledge that can improve the needed medical marijuana specifications,” Yoav Kisch, who is a sponsor of the new Israeli bill, said. “This could be a very strong, good business for the Israeli agriculture industry, which has many difficulties today.”
Though Israel has its own unique concerns for the future of cannabis, thus far it has established itself as a leader in nearly every facet of the industry. To read more about Israel’s latest moves to further its medical marijuana industry click here, [SOURCE]
For more information on ‘Israel Progresses Within Medical Marijuana Space’ contact one of our Healthway Education representatives today!